Volume 9, Number 10—October 2003
Research
Cephamycin Resistance in Clinical Isolates and Laboratory-derived Strains of Escherichia coli, Nova Scotia, Canada
Brian Clarke*, Margot Hiltz*, Heather Musgrave*, and Kevin R. Forward*
Table 1
Summary of promoter/attenuator mutations and porin changes in 18 clinical strains of Escherichia coli, arranged by pulsed-field typea
| PFGE type | Strain | MIC (μg/mL) |
Patient Location | Promoter mutations | Attenuator mutations | Outer membrane protein profile | |||
|---|---|---|---|---|---|---|---|---|---|
| FOX | CAZ | CRO | |||||||
| A |
QE1 |
16 |
<8 |
<8 |
HCC |
T insertion (–13) to consensus spacer (17 bp) |
G to A, right stem; C to T, upstream of stem/loop |
No abnormalities |
|
| A1 |
QE2 |
8 |
<8 |
<8 |
FD |
T insertion (–13) to consensus spacer (17 bp) |
C to T, upstream of stem/loop |
No abnormalities |
|
| A2 |
QE3 |
>32 |
<8 |
<8 |
Inpatient Ward A |
T insertion (–13) to consensus spacer (17 bp) |
C to T, upstream of stem/loop; C deletion, right stem |
No abnormalities |
|
| A2 |
QE4 |
16 |
<8 |
<8 |
FD |
T insertion (–13) to consensus spacer (17 bp) |
C to T, upstream of stem/loop |
No abnormalities |
|
| A3 |
QE5 |
16 |
<8 |
<8 |
ER |
T insertion (–13) to consensus spacer (17 bp) |
C to T, upstream of stem/loop; C to T, left stem |
No abnormalities |
|
| A4 |
QE6 |
>32 |
<8 |
<8 |
HCC |
T insertion (–13) to consensus spacer (17 bp) |
C to T, upstream of stem/loop |
No abnormalities |
|
| A5 |
QE7 |
>32 |
<8 |
<8 |
HCC |
T insertion (–13) to consensus spacer (17 bp) |
C to T, upstream of stem/loop; ATG deletion in loop/right stem (+27 –29) |
No abnormalities |
|
| A |
QE8 |
16 |
<8 |
<8 |
FD |
T insertion (–13) to consensus spacer (17 bp) |
C to T, upstream of stem/loop; G to A, left stem |
No abnormalities |
|
| A |
QE9 |
>32 |
16 |
<8 |
Inpatient Ward B |
T insertion (–13) to consensus spacer (17 bp) |
C to T, upstream of stem/loop; G to A, right stem |
No abnormalities |
|
| B |
QE10 |
>32 |
<8 |
<8 |
Inpatient Ward C |
C to T (–42); G to A (–18); C to T (–1) |
C to A, left stem; C to T, downstream of stem/loop |
No abnormalities |
|
| C |
QE11 |
>32 |
<8 |
<8 |
Inpatient Ward C |
G to A (–18); C to T (–1) |
C to T, downstream of stem/loop |
No abnormalities |
|
| D |
QE12 |
>32 |
<8 |
<8 |
FD |
G to A (–18); C to T (–1) |
C to T, downstream stem/loop |
Omp F- |
|
| E |
QE13 |
>32 |
16 |
<8 |
FD |
G to A in spacer (–28) |
C to T, downstream stem/loop |
No abnormalities |
|
| F |
QE14 |
8 |
<8 |
<8 |
ER |
T to A (–32), new –35 box; C to T (–11), new –10 box |
None |
No abnormalities |
|
| G |
QE15 |
>32 |
16 |
<8 |
Inpatient Ward D |
T to A (-32), new –35 box |
None |
Omp C- |
|
| H |
QE16 |
>32 |
<8 |
<8 |
HCC |
None |
C to T, downstream stem/loop |
No abnormalities |
|
| I |
QE17 |
16 |
<8 |
<8 |
FD |
None |
C to T, downstream stem/loop |
No abnormalities |
|
| J | QE18 | >32 | <8 | <8 | Inpatient Ward E | None | C deletion, right stem (+31); C to T, downstream stem/loop | No abnormalities | |
aPFGE, pulsed-field gel electrophoresis; FOX, cefoxitin; CAZ, ceftazidime; CRO, ceftriaxone, HCC, Hants Community Clinic; FD, family doctor’s office; ER, emergency room.
Page created: January 10, 2011
Page updated: January 10, 2011
Page reviewed: January 10, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.